�
LASIK pricing.
John J. Klobnak, chairman and CEO of Laser Vision Centers, Inc., told a recent
Wall Street conference that he believes refractive surgery prices are
stabilizing, though they still cover a wide range. He said his company expects
to strengthen its position in any industry shakeout.
�
FAA OKs Intacs.
The Federal Aviation Administration (FAA) has approved Intacs prescription
inserts for all classes of FAA-licensed pilots. Intacs becomes the first
non-laser option for correcting myopia to be approved by the FAA.
�
New centers.
LCA-Vision has opened three value-priced laser vision correction centers in the
Philadelphia area under its LasikPlus brand. The centers are in King of Prussia
and Chadds Ford, Pa., and Mount Laurel, N.J. LCA-Vision also reported that its
procedure volume hit a record 16,341 in the September quarter, as compared to
13,888 in the previous 3-month period.
�
Alcon gets approval.
Alcon's LadarVision System has received FDA approval for correction of hyperopia
with or without astigmatism, and for mixed astigmatism, using the LASIK
procedure. Alcon says it can now treat all types of refractive errors with LASIK.
In a related development, TLC Laser Eye Centers Inc. said it will offer these
treatments in 19 of its U.S. centers.
�
Horizon grows.
Horizon Vision Centers recently opened its seventh refractive surgery center,
this one in San Francisco. The center offers "open access" to Bay Area
ophthalmologists.
�
Lawsuit filed.
Laser Vision Centers, Inc., a leading provider of excimer lasers, related
equipment and support services for refractive surgery, filed suit in a Florida
federal court charging Laser Vision Institute with infringing on its registered
service marks.
�
Free LASIK.
Stahl Eye Centers of New York City is offering free laser vision correction to
city firefighters who are active members of the Uniformed Firefighters
Association of New York. Stahl says more than 50 firefighters have already been
treated under this program.
�
Money-back trial.
Hunkeler Eye Centers of Kansas City, Mo., is offering a 30-day trial of Intacs
prescription inserts. If not completely satisfied, patients can have the Intacs
removed and either receive a full refund or another type of refractive procedure
at no additional cost.